Susan G. Komen® Unveils $26 Million Investment in Research Funding Focused on Metastatic Breast Cancer and New Treatments
Similar Posts
Kansas Department of Health and Environment Extends Partnership with Motient to Support Interfacility Patient Transfers for all Kansas Hospitals and Correctional Facilities
Web-based patient movement platform and support services coordinated 5,100 interfacility transfers for 115 state hospitals within the past year…
Orchestra BioMed Announces Clinical Data Demonstrating a Significant and Sustained Reduction in Blood Pressure in MODERATO II Control Patients After Crossover to BackBeat Cardiac Neuromodulation Therapy
Data Shows BackBeat CNT Reduces Blood Pressure in Crossover Hypertensive Patients Orchestra BioMed, Inc., (“Orchestra BioMed” or the “Company”),…
